| Financial Year |
March 31 2023 |
| Monetary Funds |
452,971,670.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
10,293,529.00 |
| Accounts Receivable |
493,217,366.10 |
| Advances to Suppliers |
99,596,155.70 |
| Other Receivables |
8,648,567.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
262,566,880.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
539,219.70 |
| Other Current Assets |
76,170,553.36 |
| Total Current Assets |
1,405,003,942.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,049,497.27 |
| Investment Properties |
41,627,753.19 |
| Fixed Assetes |
3,915,524,566.93 |
| Under-construction Projects |
289,836,890.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
673,509,046.53 |
| R&D expenses |
-- |
| Goodwill |
1,344,815,099.26 |
| Long-Term Deferred and Prepaid Expenses |
710,247.23 |
| Deferred Income Tax Assets |
66,107,352.01 |
| Other Non-Current Assets |
15,989,300.00 |
| Sub-Total of Non-Current Assets |
6,392,097,105.53 |
| Total Assets |
7,797,101,048.09 |
| Short-Term Loans |
209,990,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,414,264.22 |
| Accounts Payable |
322,930,773.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,407,720.38 |
| Taxes Payable |
165,444,174.64 |
| Interest Payable |
-- |
| Dividend Payable |
233,831,895.43 |
| Other payables |
260,034,041.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
684,853,898.48 |
| Other Current Liabilities |
6,343,529.00 |
| Sub-Total of Current Liabilities |
2,458,213,299.38 |
| Long-term Loans |
959,920,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
307,929,869.44 |
| Other Non-Current Liabilities |
70,563,457.84 |
| Sub-Total of Non-Current Liabilities |
1,534,180,268.45 |
| Total Liabilities |
3,992,393,567.83 |
| Paid-In Capital(Or Share Stock) |
1,012,831,132.00 |
| Capital Surplus |
495,689,642.24 |
| Surplus Reserve |
181,721,556.02 |
| LESS:Treasury Stock |
100,058,093.58 |
| Undistributed Profits |
2,022,963,567.76 |
| Minority Stockholder's Interest |
159,944,180.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,644,763,300.13 |
| Owner's Equity（Stockholder's Equity） |
3,804,707,480.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,797,101,048.09 |
